Identification of pathogenesis-related microRNAs in hepatocellular carcinoma by expression profiling

Katayama,Yuki; Maeda,Moegi; Miyaguchi,Ken; Nemoto,Shota; Yasen,Mahmut; Tanaka,Shinji; Mizushima,Hiroshi; Fukuoka,Yutaka; Arii,Shigeki; Tanaka,Hiroshi

doi:10.3892/ol.2012.810

Identification of pathogenesis-related microRNAs in hepatocellular carcinoma by expression profiling

Authors:
- Yuki Katayama
- Moegi Maeda
- Ken Miyaguchi
- Shota Nemoto
- Mahmut Yasen
- Shinji Tanaka
- Hiroshi Mizushima
- Yutaka Fukuoka
- Shigeki Arii
- Hiroshi Tanaka
View Affiliations

Affiliations: Department of Bioinformatics, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan, Department of Hepato-Biliary-Pancreatic Surgery, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan, Center for Public Health Informatics, National Institute of Public Health, Tokyo, Japan, Department of Biosystem Modeling, Graduate School of Biomedical Science, Tokyo Medical and Dental University, Tokyo, Japan
Published online on: July 18, 2012 https://doi.org/10.3892/ol.2012.810
Pages: 817-823

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Hepatocellular carcinoma (HCC) is one of the most common malignant tumors of the liver. Since postoperative recurrence and intrahepatic metastases occur frequently, the postoperative 5-year survival rate is low. To investigate the molecular mechanisms of HCC progression, mRNA as well as microRNA (miRNA) expression levels have been profiled in various studies. However, no previous study has comprehensively compared the expression of miRNAs in HCC patients with various clinical features using the tumor and surrounding non-tumor tissues and normal liver samples. In this study, we profiled the expression of miRNAs in tumor and non-tumor tissues from 40 HCC patients with heterogeneous pathogenesis and 6 surrounding non-tumor tissues from patients with metastatic liver cancer. To identify miRNAs specific to each disease state, we comprehensively compared the expression of miRNAs in various combinations. The results indicate that the expression of many known as well as novel miRNAs was altered in patients with the hepatitis C virus infection compared with those with the hepatitis B virus and without any virus infection. The following miRNAs were downregulated in the tumor and non-tumor tissues, and thus could serve as novel biomarkers for chronic liver diseases: miR-18b*, miR-296-5p, miR-557, miR-581, miR-625*, miR-1228, miR-1249 and miR-2116*. Similarly, miR-129*, miR-146b-3p and miR-448 are novel candidates for HCC biomarkers regardless of virus infection.

View Figures

View References

1.	HB El-SeragKL RudolphHepatocellular carcinoma: epidemiology and molecular carcinogenesisGastroenterology13225572576200710.1053/j.gastro.2007.04.06117570226
2.	H BlumHepatocellular carcinoma: therapy and preventionWorld J Gastroenterol1173917400200516437707
3.	M CrampHBV + HCV = HCC?Gut451681691999
4.	Y SoiniSC ChiaWP BennettAn aflatoxin-associated mutational hotspot at codon 249 in the p53 tumor suppressor gene occurs in hepatocellular carcinomas from MexicoCarcinogenesis1710071012199610.1093/carcin/17.5.10078640905
5.	P BoffettaL MatisaneKA MundtLD DellMeta-analysis of studies of occupational exposure to vinyl chloride in relation to cancer mortalityScand J Work Environ Health29220229200310.5271/sjweh.72512828392
6.	H TsukumaT HiyamaA OshimaA case-control study of hepatocellular carcinoma in Osaka, JapanInt J Cancer45231236199510.1002/ijc.2910450205
7.	F DonatoA TaggerU GelattiAlcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and womenAm J Epidemiol155323333200210.1093/aje/155.4.32311836196
8.	S VoliniaGA CalinCG LiuA microRNA expression signature of human solid tumors defines cancer gene targetsProc Natl Acad Sci USA10322572261200610.1073/pnas.051056510316461460
9.	N YanaiharaN CaplenE BowmanUnique micro RNA molecular profiles in lung cancer diagnosis and prognosisCancer Cell9189198200610.1016/j.ccr.2006.01.02516530703
10.	EJ LeeY GusevJ JiangExpression profiling identifies microRNA signature in pancreatic cancerInt J Cancer12010461054200710.1002/ijc.2239417149698
11.	Y MurakamiT YasudaK SaigoComprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissuesOncogene2525372545200610.1038/sj.onc.120928316331254
12.	A BudhuHL JiaM ForguesIdentification of metastasis-related microRNAs in hepatocellular carcinomaHepatology47897907200810.1002/hep.2216018176954
13.	H VarnhortU DrebberF SchulzeMicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinomaHepatology4712231232200810.1002/hep.2215818307259
14.	Y LaderioG CouchyC BalabaudMicroRNA profiling in hepatocellular tumor is associated with clinical features and oncogene/tumor suppressors gene mutationsHepatology4719551963200810.1002/hep.2225618433021
15.	W LiL XieX HeDiagnostic and prognositic implications of microRNAs in human hepatocellular carcinomaInt J Cancer12316161622200810.1002/ijc.2369318649363
16.	S UraM HondaT YamashitaDifferential microRNA expression between hapatitis B and hepatitis C leading disease progression to hepatocellular carcinomaHepatology4910981112200910.1002/hep.2274919173277
17.	S ToffaninY HoshidaA LachenmayerMicroRNA-based classification of hepatocellular carcinoma and oncogenic role of miR-517aGastoenterology14016181628201110.1053/j.gastro.2011.02.00921324318
18.	M YasenH MizushimaK MogushiExpression of Aurora B and alterative variant forms in hepatocellular carcinoma and adjacent tissueCancer Sci100472480200910.1111/j.1349-7006.2008.01068.x19134008
19.	L GramantieriF FornariE CallegariMicroRNA involvement in hepatocellular carcinomaJ Cell Mol Med1221892204200810.1111/j.1582-4934.2008.00533.x19120703
20.	RN AravalliCJ SteerNK CressmanMolecular mechanisms of hepatocellular carcinomaHepatology4820472063200810.1002/hep.22580
21.	J JiXW WangNew kids on the blockCancer Biol Therapy816831690200910.4161/cbt.8.18.8898
22.	L LiangCM WongQ YingMicroRNA-125b suppressed human liver cancer cell proliferation and metastasis by directly targeting oncogene LIN28BHepatology5217311740201010.1002/hep.2390420827722
23.	M OsakiF TakeshitaT OchiyaMicroRNAs as biomarkers and therapeutic drugs in human cancerBiomarkers13658670200810.1080/1354750080264657219096960
24.	J TakamizawaH KonishiK YanagisawaReduced expression of the let-7 micro RNAs in human lung cancers in association with shortened postoperative survivalCancer Res6437533756200410.1158/0008-5472.CAN-04-063715172979
25.	M FabbriR GarzonA CimminoMicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3BProc Natl Acad Sci USA1041580515810200710.1073/pnas.070762810417890317
26.	GT BommerI GerinY Fengp53-mediated activation of miRNA34 candidate tumor-suppressor genesCurr Biol1712981307200710.1016/j.cub.2007.06.06817656095
27.	M CrawfordE BrawnerK BattleMicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell linesBiochem Biophys Res Commun373607612200810.1016/j.bbrc.2008.06.09018602365
28.	Y HayashitaH OsadaY TatematsuA polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferationCancer Res6596289632200510.1158/0008-5472.CAN-05-235216266980
29.	S VoliniaGA CalinCG LiuA microRNA expression signature of human solid tumors defines cancer gene targetsProc Natl Acad Sci USA10322572261200610.1073/pnas.051056510316461460
30.	M GarofaloC QuintavalleG Di LevaMicroRNA signatures of TRAIL resistance in human non-small cell lung cancerOncogene2738453855200810.1038/onc.2008.618246122
31.	N YanaiharaN CaplenE BowmanUnique microRNA molecular profiles in lung cancer diagnosis and prognosisCancer Cell9189198200610.1016/j.ccr.2006.01.02516530703
32.	Z HuJ ChenT TianGenetic variants of miRNA sequences and non-small cell lung cancer survivalJ Clin Invest11826002608200818521189
33.	SL YuHY ChenGC ChangMicroRNA signature predicts survival and relapse in lung cancerCancer Cell134857200810.1016/j.ccr.2007.12.00818167339
34.	A MarkouEG TsarouchaL KaklamanisM FotinouV GeogouliasES LianidouPrognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCRClin Chem5416961704200810.1373/clinchem.2007.10174118719201
35.	LX YanXF HuangQ ShaoMicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosisRNA1423482360200810.1261/rna.103480818812439
36.	SH ChanCW WuAF LiCW ChiWC LinmiR-21 microRNA expression in human gastric carcinomas and its clinical associationAnticancer Res28907911200818507035
37.	T SchepelerJT ReinertMS OstenfeldDiagnostic and prognostic microRNAs in stage II colon cancerCancer Res6864166424200810.1158/0008-5472.CAN-07-611018676867
38.	G ChildsM FazzariG KungLow-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinomaAm J Pathol174736745200910.2353/ajpath.2009.08073119179615
39.	C RoldoE MissiagliaJP HaganMicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behaviorJ Clin Oncol2446774684200610.1200/JCO.2005.05.5194
40.	G MarcucciMD RadmacherK MaharryMicroRNA expression in cytogenetically normal acute myeloid leukemiaN Engl J Med35819191928200810.1056/NEJMoa07425618450603
41.	GA CalinM FerracinA CimminoA microRNA signature associated with prognosis and progression in chronic lymphocytic leukemiaN Engl J Med35317931801200510.1056/NEJMoa05099516251535
42.	L LuD KatsarosIA de la LongraisO SochircaH YuHypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosisCancer Res671011710122200710.1158/0008-5472.CAN-07-254417974952
43.	Y GuoZ ChenL ZhangDistinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinomaCancer Res682633200810.1158/0008-5472.CAN-06-441818172293
44.	SS ChimTK ShingEC HungDetection and characterization of placental microRNAs in material plasmaClin Chem54482490200810.1373/clinchem.2007.09797218218722
45.	S GiladE MeiriY YogevSerum microRNAs are promising biomarkersPLoS One3e3148200810.1371/journal.pone.000314818773077
46.	PS MitchelRA ParkinEM KrohCirculating microRNAs as stable blood-based markers for cancer detectionProc Natl Acad Sci USA1051051310518200810.1073/pnas.080454910518663219
47.	CH LawrieCd CooperE BallabioJ ChiD TramontiCS HattonAberrant expression of microRNA biosynthetic pathways components is a common feature of haematological malignancyBr J Hematol141672675200819298586
48.	R DiazJ SilvaJM GarciaDeregulated expression of miR-106a predicts survival in human colon cancer patientsGenes Chromosomes Cancer47794802200810.1002/gcc.2058018521848
49.	K ScheeO FodstadK FlatmarkMicroRNAs as biomarkers in colorectal cancerAm J Patho17715921599201010.2353/ajpath.2010.10002420829435
50.	WKK WuCW LeeCH ChoD FanK WuJ YuJJY SungMicroRNA dysregulation in gastric cancer: a new player enters the gameOncogene2957615671201010.1038/onc.2010.35220802530
51.	J ZavadilH YeZ LiuProfiling and functional analyses of microRNAs and their target gene products in human uterine leiomyomasPLoS One5e12362201010.1371/journal.pone.001236220808773
52.	MV IorioC PiovanCM CroceInterplay between microRNAs and the epigenetic machinery: an intricate networkBoichim Biophys Acta1799694701201010.1016/j.bbagrm.2010.05.00520493980
53.	N ValeriI VanniniF FaniniF CaloreB AdairM FabbriEpigenetics, miRNAs, and human cancer: a new chapter in human gene regulationMamm Genome20573580200910.1007/s00335-009-9206-519697081
54.	A SchaeferM JungG KristiansenMicroRNAs and cancer: current state and future perspectives in urologic oncologyUrologic Oncol28413201010.1016/j.urolonc.2008.10.02119117772
55.	R GarzonG MarcucciCM CroceTargeting microRNAs in cancer: rationale, strategies and challengesNat Rev Drug Discov9775789201010.1038/nrd317920885409
56.	GA CalinCG LiuC SevignaniMicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemiasProc Natl Acad Sci USA1011175511760200410.1073/pnas.040443210115284443
57.	D BetelA KoppalP AngiusC SanderC LeslieComprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sitesGenome Biol11R90201010.1186/gb-2010-11-8-r9020799968
58.	JU KangSH KooKC KwonJW ParkJM KimGain at chromosomal region 5p15.33, containing TERT, is the most frequent genetic event in early stages of non-small cell lung cancerCancer Genet Cytogenet82111200810.1016/j.cancergencyto.2007.12.00418328944
59.	Y YamamotoY ChochiH MatuyamaGain of 5p15.33 is associated with progression of bladder cancerOncology72132138200710.1159/000111132
60.	K YuK GanesanLK TanA precisely regulated gene expression cassette potentially modulates metastasis and survival in multiple solid cancersPLoS Genet4e1000129200810.1371/journal.pgen.100012918636107
61.	D BodmerM EleveldE Kater-BaatsDisruption of a novel MFS transporter gene, DIRC2, by a familial renal cell carcinoma-associated t(2;3)(q35;q21)Hum Mol Genet11641649200210.1093/hmg/11.6.64111912179
62.	Y WatanabeF YamasakiY KajiwaraExpression of phosphoprotein enriched in astrocytes 15 kDa (PEA-15) in astrocytic tumors: a novel approach of correlating malignancy grade and prognosisJ Neurooncol100449457201010.1007/s11060-010-0201-120455002